Clinical Trial Update: The Effects of HIV Protease Inhibitors in Severe Sepsis [Phase 1]

View source ↗

Summary

A Phase 1 trial conducted by Mayo Clinic evaluated the effects of HIV protease inhibitors in patients with severe sepsis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• HIV protease inhibitors (unspecified)

Snippet

Sponsor: Mayo Clinic | Conditions: Sepsis | Phase 1 | Status: COMPLETED